The TMB in double-mutant CRC was significantly higher than that in KRAS-mutant CRC (p < 0.01, Figure 2A) but was not significantly higher than that in BRAF-mutant CRC (p < 0.026, Figure 2B). This evidence concerns the gene KRAS and colorectal carcinoma.